Evaluation of PIVKA-II efficiency in the diagnosis of early hepatocellular carcinoma

被引：0

作者：

Saitta, Carlo ^{[2
]}

Raffa, Giuseppina ^{[2
]}

di Tocco, Francesca Casuscelli ^{[2
]}

Brancatelli, Santa ^{[2
]}

Alibrandi, Angela ^{[3
]}

Raimondo, Giovanni ^{[2
]}

Pollicino, Teresa ^{[1
]}

机构：

[1] Univ Hosp Messina, Pediat Gynecol Microbiol & Biomed Sci, Messina, Italy

[2] Univ Hosp Messina, Clin & Expt Med, Messina, Italy

[3] Univ Messina, Messina, Italy

来源：

HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1898

引用

页码：1134A / 1134A

页数：1

共 50 条

[11] Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma [J].

Guarneri, Valeria ;

Loggi, Elisabetta ;

Serra, Carla ;

Vukotic, Ranka ;

Cevenini, Monica ;

Cursaro, Carmela ;

Scuteri, Alessandra ;

Vitale, Giovanni ;

Margotti, Marzia ;

Galli, Silvia ;

Galli, Claudio ;

Andreone, Pietro .

JOURNAL OF HEPATOLOGY, 2020, 73 :S631-S632

[12] Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma [J].

Jin, Yujiao ;

Xu, Aifang .

JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024,

[13] CLINICOPATHOLOGICAL SIGNIFICANCE OF PIVKA-II AND AFP IN HEPATOCELLULAR-CARCINOMA [J].

NAKAGAWA, T ;

SEKI, T ;

SHIRO, T ;

WAKABAYASHI, M ;

ITOH, T ;

IMAMURA, M ;

TAMAI, T ;

SHIOZAKI, Y ;

INOUE, K ;

OKAMURA, A .

HEPATOLOGY, 1995, 22 (04) :322-322

[14] Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma [J].

Guarneri, Valeria ;

Loggi, Elisabetta ;

Ramacieri, Giuseppe ;

Serra, Carla ;

Vukotic, Ranka ;

Vitale, Giovanni ;

Scuteri, Alessandra ;

Cursaro, Carmela ;

Margotti, Marzia ;

Galli, Silvia ;

Caracausi, Maria ;

Brodosi, Lucia ;

Gabrielli, Filippo ;

Andreone, Pietro .

CANCERS, 2025, 17 (02)

[15] Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma [J].

Tian, Shan ;

Chen, Yongyi ;

Zhang, Yimin ;

Xu, Xiaohong .

JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)

[16] The utility of PIVKA-II as a biomarker for treatment response in hepatocellular carcinoma [J].

Patricia Varquez, Charmaine ;

Eternity Labio, Madalinee .

GUT, 2023, 72 (SUPPL_1) :A173-A173

[17] The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population [J].

Ng, Wai-Yoong ;

Lim, Daniel Yan-Zheng ;

Tan, Si-Yu ;

Chang, Jason Pik-Eu ;

Krishnamoorthy, Thinesh Lee ;

Lim, Chee-Hooi ;

Tan, Damien Meng-Yew ;

Ekstrom, Victoria Sze-Min ;

Goh, George Boon-Bee ;

Cheah, Mark Chang-Chuen ;

Kumar, Rajneesh ;

Yeo, Chin-Pin ;

Tan, Chee-Kiat .

ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (02) :108-110

[18] EVALUATION OF PIVKA-II AS A PREDICTOR MARKER FOR PORTAL VEIN THROMBOSIS IN HEPATOCELLULAR CARCINOMA PATIENTS [J].

Ayoub, M. ;

Hemida, K. ;

Kamai, W. ;

Riad, G. ;

Adele, N. ;

Ayoub, D. .

HAEMATOLOGICA, 2013, 98 :209-209

[19] Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia [J].

Miskad, UA ;

Yano, Y ;

Nakaji, M ;

Kishi, S ;

Itoh, H ;

Kim, SR ;

Ku, YS ;

Kuroda, Y ;

Hayashi, Y .

PATHOLOGY INTERNATIONAL, 2001, 51 (12) :916-922

[20] PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma - A Pilot Study [J].

Svobodova, Sarka ;

Karlikova, Marie ;

Topolcan, Ondrej ;

Pecen, Ladislav ;

Pestova, Martina ;

Kott, Otto ;

Treska, Vladislav ;

Slouka, David ;

Kucera, Radek .

IN VIVO, 2018, 32 (06) :1551-1554

← 1 2 3 4 5 →